Since the tumor microenvironment plays a significant role in the prognosis of breast cancers, investigators explored whether combining an IFN-γ gene signature with an ECM gene signature would further refine the prediction of prognosis, specifically in high grade breast cancers [15]. This evidence concerns the gene IFNG and neoplasm.